Back

Impact of eligibility to a randomized controlled trial in prognosis after Mitraclip implantation

22 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Valvular Heart Disease & Interventional Cardiology Intervention HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Gualter Silva

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

20 More presentations in this session

Presentation thumbnail
Additive value of soluble ST2 to NT-proBNP for more accurate patient risk stratification and long-term survival prediction after TAVI
Miss A. Moya (Aalst, BE)
Abstract Slides
Presentation thumbnail
Left ventricular filling pressure as a determinant of risk stratification in patients undergoing transcatheter aortic valve implantation
Doctor K. Byczkowska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Assessment left atrial geometry and function by cardiac magnetic resonance imaging in aortic stenosis
Associate Professor L. Agoston Coldea (Cluj Napoca, RO)
Abstract Slides
Presentation thumbnail
Endocarditis: who are the true bad boys?
Doctor P. Alves da Silva (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Long-term prognostic implications of inflammatory and nutritional status in patients undergoing valvular heart surgery
Miss D. Hung (Hong Kong, HK)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Valvular Heart Disease & Interventional Cardiology

The Event

Event poster

Heart Failure 2022

22 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources